Login to Your Account


BARCELONA, Spain – What may well be Europe's least known cell therapy company has just begun a phase III trial of its lead program in a notoriously challenging indication. Rexgenero Ltd. began recruiting diabetic patients with CLI last week.

BARCELONA, Spain – With drug pricing in the political crosshairs and the first gene therapies advancing toward the market, the health care sector will have to figure how to put a price tag on therapies that provide durable, curative responses.

LONDON – The EMA is working on a worst-case scenario that it will lose 50 percent of its 890 staff when it is forced to relocate from London.

More EUROPE Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: